CheckMate914
Por um escritor misterioso
Descrição
Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories
Clinical Trials in Genitourinary Cancers: CheckMate 914, KEYNOTE-992, and KEYNOTE-991
CheckMate 914 Archives
.png)
ASCO热评丨盛锡楠教授：肾癌领域治疗进展-肿瘤瞭望
Home - UROONCO Kidney Cancer
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Enrique Grande on X: 🔘 On @TheLancet - Assessing the efficacy and safety of adjuvant nivolumab + ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914) #immunotherapy #kidneycancer
IJMS, Free Full-Text
ESMO22: CheckMate 914-studie naar adjuvant nivo+ipi bij RCC behaalt primaire uitkomstmaat niet - Oncologie
Adjuvant immunotherapy does not improve DFS in renal cancer
Singer
The Search for the Optimal Immunotherapy Sequencing in the Perioperative Setting of RCC
de
por adulto (o preço varia de acordo com o tamanho do grupo)
